IMAC (BACK) Competitors $0.07 0.00 (-2.83%) As of 12:40 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BACK vs. OTRK, BTTX, UPHL, OPGN, ACONW, AONC, DHACW, FMS, LFMDP, and OTRKPShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Ontrak (OTRK), Better Therapeutics (BTTX), UpHealth (UPHL), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), and Ontrak (OTRKP). These companies are all part of the "healthcare" industry. IMAC vs. Its Competitors Ontrak Better Therapeutics UpHealth OpGen Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak IMAC (NASDAQ:BACK) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability. Do analysts recommend BACK or OTRK? Ontrak has a consensus price target of $3.00, indicating a potential upside of 7,400.00%. Given Ontrak's stronger consensus rating and higher possible upside, analysts plainly believe Ontrak is more favorable than IMAC.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IMAC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in BACK or OTRK? 5.8% of IMAC shares are owned by institutional investors. Comparatively, 12.9% of Ontrak shares are owned by institutional investors. 12.3% of IMAC shares are owned by company insiders. Comparatively, 1.9% of Ontrak shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, BACK or OTRK? IMAC has a beta of 2.36, suggesting that its share price is 136% more volatile than the S&P 500. Comparatively, Ontrak has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500. Which has higher earnings and valuation, BACK or OTRK? IMAC has higher earnings, but lower revenue than Ontrak. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIMAC$72.05K2.07-$9.42MN/AN/AOntrak$10.18M0.02-$25.49M-$15.810.00 Does the media prefer BACK or OTRK? In the previous week, IMAC had 1 more articles in the media than Ontrak. MarketBeat recorded 2 mentions for IMAC and 1 mentions for Ontrak. IMAC's average media sentiment score of 1.25 beat Ontrak's score of 0.00 indicating that IMAC is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IMAC 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Ontrak 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is BACK or OTRK more profitable? IMAC has a net margin of 0.00% compared to Ontrak's net margin of -274.20%. IMAC's return on equity of 0.00% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets IMACN/A N/A -325.44% Ontrak -274.20%-269.88%-128.35% SummaryIMAC beats Ontrak on 8 of the 14 factors compared between the two stocks. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BACK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BACK vs. The Competition Export to ExcelMetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$149K$149K$5.78B$9.92BDividend YieldN/AN/A6.67%4.52%P/E RatioN/AN/A75.6726.67Price / Sales2.072.07554.40206.13Price / CashN/AN/A37.1158.92Price / Book-0.11N/A11.446.09Net Income-$9.42M-$9.42M$3.28B$266.14M7 Day PerformanceN/AN/A0.78%0.22%1 Month PerformanceN/AN/A7.07%4.08%1 Year PerformanceN/AN/A59.61%23.89% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BACKIMACN/A$0.07-2.8%N/A-95.5%$149K$72.05K0.00180News CoveragePositive NewsOTRKOntrak1.8278 of 5 stars$0.07-22.7%$3.00+4,167.4%-98.7%$297K$10.18M0.00250News CoveragePositive NewsGap UpBTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750OPGNOpGenN/AN/AN/AN/A$1K$2.67M0.00100Short Interest ↓ACONWAclarionN/A$0.04-0.3%N/A+11.4%$0.00$62.95K0.007Positive NewsAONCAmerican Oncology NetworkN/A$11.18-2.8%N/A+217.7%$0.00$1.34B0.001,520Short Interest ↑DHACWDigital Health AcquisitionN/A$0.03-11.7%N/A-36.0%$0.00N/A0.00N/AGap UpFMSFresenius Medical Care AG & Co. KGaA3.8743 of 5 stars$25.07-1.6%$27.80+10.9%+24.8%$0.00$20.63B20.551,384News CoverageAnalyst ForecastLFMDPLifeMDN/A$24.00flatN/A+9.3%$0.00$245.56M0.00230OTRKPOntrakN/A$0.02-38.9%N/A-84.0%$0.00$10.84M0.00250Gap Down Related Companies and Tools Related Companies Ontrak Competitors Better Therapeutics Competitors UpHealth Competitors OpGen Competitors Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors Fresenius Medical Care AG & Co. KGaA Competitors LifeMD Competitors Ontrak Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BACK) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
